Literature DB >> 19328197

alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition.

Céline Defilles1, Jean-Claude Lissitzky, Marie-Pierre Montero, Frédéric André, Charles Prévot, Estelle Delamarre, Naziha Marrakchi, José Luis, Véronique Rigot.   

Abstract

Crosstalk between integrins is involved in the regulation of various cell functions including cell migration. Here we identify the interplay between the integrins alphavbeta5/beta6 and alpha2beta1 during cell migration toward type I collagen. Human colon cancer cell lines HT29-D4 and SW480 were used as cell models. To improve our understanding of the consequences of alphavbeta5/beta6 function on alpha2beta1, we decreased the expression of alphav integrins by either siRNA or lysosomal targeting strategies or inhibited their function using, as antagonists, blocking antibodies or disintegrins. In all cases, we observed a greatly enhanced alpha2beta1 integrin-dependent cell migration associated with focal adhesion rearrangements and increased outside-in signaling as demonstrated by elevated phosphorylation of focal adhesion kinase and MAPKinase (ERK1 and ERK2). The alphavbeta5/beta6-dependent limitation of alpha2beta1 function could be overridden by TS2/16, an activating anti-beta1 antibody. Interestingly, compared to control cells, the pharmacological inhibition of PI3Kinase or the siRNA-mediated knockdown of AKT had little effect on the high alpha2beta1-mediated cell migration observed in the absence of alphav integrins or following activation of alpha2beta1 integrins by the TS2/16. These results suggest that integrins alphavbeta5/beta6 repress alpha2beta1 possibly by interfering with their activation process and thereby modify the cell signaling regulation of alpha2beta1-mediated migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19328197     DOI: 10.1016/j.yexcr.2009.03.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis.

Authors:  John J Grzesiak; Hop S Tran Cao; Douglas W Burton; Sharmeela Kaushal; Fabian Vargas; Paul Clopton; Cynthia S Snyder; Leonard J Deftos; Robert M Hoffman; Michael Bouvet
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

Review 2.  Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Authors:  Aimee Alphonso; Suresh K Alahari
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.

Authors:  Julie Devallière; Mathias Chatelais; Juliette Fitau; Nathalie Gérard; Philippe Hulin; Laura Velazquez; Christopher E Turner; Béatrice Charreau
Journal:  FASEB J       Date:  2012-03-21       Impact factor: 5.191

4.  A collapsin response mediator protein 2 isoform controls myosin II-mediated cell migration and matrix assembly by trapping ROCK II.

Authors:  Atsuko Yoneda; Marie Morgan-Fisher; Robin Wait; John R Couchman; Ulla M Wewer
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

5.  Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.

Authors:  Thomas Graillon; Céline Defilles; Amira Mohamed; Christophe Lisbonis; Anne-Laure Germanetti; Olivier Chinot; Dominique Figarella-Branger; Pierre-Hugues Roche; Tarek Adetchessi; Stéphane Fuentes; Philippe Metellus; Henry Dufour; Alain Enjalbert; Anne Barlier
Journal:  J Neurooncol       Date:  2015-05-27       Impact factor: 4.130

6.  The deubiquitylase USP10 regulates integrin β1 and β5 and fibrotic wound healing.

Authors:  Stephanie R Gillespie; Liana J Tedesco; Lingyan Wang; Audrey M Bernstein
Journal:  J Cell Sci       Date:  2017-08-29       Impact factor: 5.285

7.  Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Zequn Li; Pengfei Lin; Chao Gao; Cheng Peng; Song Liu; Huijie Gao; Ben Wang; Jiayong Wang; Jun Niu; Weibo Niu
Journal:  Tumour Biol       Date:  2015-11-07

8.  Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state.

Authors:  Alexandra Canonici; Emilie Pellegrino; Carole Siret; Chloé Terciolo; Dorota Czerucka; Sonia Bastonero; Jacques Marvaldi; Dominique Lombardo; Véronique Rigot; Frédéric André
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly.

Authors:  Lingyan Wang; Benjamin S Pedroja; Erin E Meyers; Angelo L Garcia; Sally S Twining; Audrey M Bernstein
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

10.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.